| RS539613654 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Ehlers-Danlos syndrome |
| RS539621646 |
WDR19
|
Health Risk |
Conflicting classifications of pathogenicity |
Senior-Loken syndrome 8, Asphyxiating thoracic dystrophy 5 |
| RS539628480 |
NUP107
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS539657017 |
ITPR1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS539662922 |
GNAO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, Inborn genetic diseases |
| RS539670390 |
CBS
|
Health Risk |
Conflicting classifications of pathogenicity |
Classic homocystinuria, HYPERHOMOCYSTEINEMIA |
| RS539671529 |
STRADA
|
Health Risk |
Conflicting classifications of pathogenicity |
Polyhydramnios, megalencephaly |
| RS539676759 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS539684481 |
OTOG
|
Health Risk |
Likely pathogenic |
OTOG-related disorder, OTOG-related disorder |
| RS539688337 |
LOXHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS539690413 |
DOCK6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS539691388 |
LRRK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS539699299 |
SLC26A4
|
Health Risk |
Likely pathogenic |
Pendred syndrome, Autosomal recessive nonsyndromic hearing loss 4 |
| RS5397 |
SLC2A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi-Bickel syndrome, Type 2 diabetes mellitus |
| RS539703340 |
GLDN
|
Health Risk |
Pathogenic |
Lethal congenital contracture syndrome 11, Polyhydramnios |
| RS539706443 |
HOXB13
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Prostate cancer |
| RS539710314 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS539716201 |
NPHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis, Finnish congenital nephrotic syndrome |
| RS539727841 |
GRM6
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS539734440 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 5 with or without anosmia, CHARGE syndrome |
| RS539736116 |
WDR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Lazy leukocyte syndrome |
| RS539737269 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac arrhythmia, Brugada syndrome |
| RS539739051 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized juvenile polyposis/juvenile polyposis coli, Hereditary cancer-predisposing syndrome |
| RS539740208 |
MYH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS539741111 |
NLRP12
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cold autoinflammatory syndrome 2, Familial cold autoinflammatory syndrome 2 |
| RS539743701 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS539753097 |
TMEM43
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 5, Cardiomyopathy |
| RS539758749 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS539760679 |
KBTBD13
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 6, Inborn genetic diseases |
| RS539763601 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS539765620 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Alport syndrome, Alport syndrome 3b |
| RS539767366 |
RECQL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Baller-Gerold syndrome, Hereditary cancer-predisposing syndrome |
| RS539768252 |
PDE6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Congenital stationary night blindness autosomal dominant 2 |
| RS539769126 |
TTC21B
|
Health Risk |
Conflicting classifications of pathogenicity |
Jeune thoracic dystrophy, Nephronophthisis |
| RS539772339 |
MAT1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hepatic methionine adenosyltransferase deficiency, Hepatic methionine adenosyltransferase deficiency |
| RS539772713 |
PRODH
|
Health Risk |
Conflicting classifications of pathogenicity |
Proline dehydrogenase deficiency, Proline dehydrogenase deficiency |
| RS539784682 |
OTOG
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS539793378 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS5398 |
SLC2A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi-Bickel syndrome, Type 2 diabetes mellitus |
| RS539800267 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS539810910 |
NUP85
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS539811607 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
COL11A1-related disorder, COL11A1-related disorder |
| RS539815742 |
ZNF335
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS539819851 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, NEB-related disorder |
| RS539821357 |
DSG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 10, Cardiomyopathy |
| RS539823013 |
CTSD
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS539829239 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Inborn genetic diseases |
| RS539832134 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS539836429 |
CYP11B2
|
Health Risk |
Pathogenic/Likely pathogenic |
Corticosterone methyl oxidase type II deficiency, Corticosterone 18-monooxygenase deficiency |
| RS539836931 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS539841659 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS539843065 |
SLC7A7
|
Health Risk |
Conflicting classifications of pathogenicity |
Lysinuric protein intolerance, Autoinflammatory syndrome |
| RS539850739 |
AFG2A
|
Health Risk |
Likely pathogenic |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Syndromic complex neurodevelopmental disorder |
| RS539856643 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS539858835 |
GRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 3, Fraser syndrome 3 |
| RS539865839 |
SLC12A1
|
Health Risk |
Pathogenic |
— |
| RS539868284 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS539875477 |
MYH14
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS539898848 |
PYGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type VI |
| RS539909716 |
TFR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary hemochromatosis, Hemochromatosis type 3 |
| RS539917500 |
PRKN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS539921712 |
MED13
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS539921893 |
RORA
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual developmental disorder with or without epilepsy or cerebellar ataxia, Intellectual developmental disorder with or without epilepsy or cerebellar ataxia |
| RS539925873 |
GBE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type IV |
| RS539927192 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS539929888 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS539945827 |
TMEM43
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 5, Cardiovascular phenotype |
| RS539948794 |
DNMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary sensory neuropathy-deafness-dementia syndrome, Hereditary sensory neuropathy-deafness-dementia syndrome |
| RS539960851 |
NBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly, normal intelligence and immunodeficiency |
| RS539962457 |
LIPT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Encephalopathy, neonatal severe |
| RS539966138 |
IL2RA
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency due to CD25 deficiency, Immunodeficiency due to CD25 deficiency |
| RS539975714 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS539978799 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS539986030 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS539992718 |
CC2D1A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS539992721 |
C3
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome, Complement component 3 deficiency |
| RS539995816 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS540000393 |
POR
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency, Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency |
| RS540003024 |
PROM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS540006729 |
CTNNA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 13, Arrhythmogenic right ventricular dysplasia 13 |
| RS540008835 |
SLC26A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Pendred syndrome, Pendred syndrome |
| RS540014314 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Primary dilated cardiomyopathy |
| RS540023428 |
OPA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Optic atrophy 3, 3-Methylglutaconic aciduria type 3 |
| RS540023880 |
SLC2A10
|
Health Risk |
Conflicting classifications of pathogenicity |
Arterial tortuosity syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS540038644 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS540049109 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Sarcoma, Ovarian serous cystadenocarcinoma |
| RS540051071 |
TNS2
|
Health Risk |
Conflicting classifications of pathogenicity |
TNS2-related disorder, TNS2-related disorder |
| RS540053239 |
PCYT1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome, Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome |
| RS540061657 |
SERPINH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type 10, Osteogenesis imperfecta type 10 |
| RS540072010 |
TRIM63
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Hypertrophic cardiomyopathy |
| RS540087535 |
ATP1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemiplegic migraine, Familial hemiplegic migraine |
| RS540088883 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Central core myopathy, Malignant hyperthermia |
| RS540089974 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS540090187 |
STAR
|
Health Risk |
Likely pathogenic |
Congenital lipoid adrenal hyperplasia due to STAR deficency, Congenital lipoid adrenal hyperplasia due to STAR deficency |
| RS540093295 |
SLC26A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Pendred syndrome, Autosomal recessive nonsyndromic hearing loss 4 |
| RS540094720 |
RGR
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS540108477 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS540113579 |
DSG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Arrhythmogenic right ventricular dysplasia 10 |
| RS540115992 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS540117605 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Distal myopathy with posterior leg and anterior hand involvement, Hypertrophic cardiomyopathy 26 |